• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 3. An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopy
  Michael Kappl,Paul M. Young,Daniela Traini,Sanyog Jain RSC Adv., 2016,6, 25789-25798
• 4. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylphosphines and derivatives

Recent Advances in Allyldiphenylphosphine Oxide (CAS 4141-48-4) Research: Applications and Mechanisms in Chemical Biology and Medicine

Allyldiphenylphosphine oxide (CAS 4141-48-4) has emerged as a compound of significant interest in chemical biology and medicinal research due to its versatile applications in organic synthesis, catalysis, and drug development. Recent studies have highlighted its role as a key intermediate in the synthesis of phosphine-containing ligands, which are crucial for transition-metal-catalyzed reactions. This research brief consolidates the latest findings on the compound's structural properties, reactivity, and potential therapeutic applications, providing a comprehensive overview for professionals in the field.

One of the most notable advancements in the study of Allyldiphenylphosphine oxide is its application in asymmetric catalysis. A 2023 study published in the Journal of the American Chemical Society demonstrated its efficacy as a chiral auxiliary in palladium-catalyzed cross-coupling reactions, enabling the synthesis of enantiomerically pure pharmaceuticals. The study revealed that the compound's unique electronic and steric properties facilitate high enantioselectivity, making it a valuable tool for the production of complex drug molecules.

In addition to its catalytic applications, Allyldiphenylphosphine oxide has shown promise in medicinal chemistry. Research conducted at the University of Cambridge in 2024 identified its potential as a scaffold for designing kinase inhibitors. The compound's phosphine oxide moiety was found to interact selectively with ATP-binding sites in kinases, offering a novel approach to targeting cancer-related pathways. Preliminary in vitro studies reported a significant reduction in tumor cell proliferation, suggesting its potential as a lead compound for anticancer drug development.

Further investigations into the mechanistic aspects of Allyldiphenylphosphine oxide have revealed its role in modulating oxidative stress responses. A recent publication in Chemical Communications (2024) detailed its ability to scavenge reactive oxygen species (ROS) in neuronal cells, highlighting its neuroprotective properties. This finding opens new avenues for research into neurodegenerative diseases, such as Alzheimer's and Parkinson's, where oxidative stress plays a critical role in disease progression.

The synthesis and characterization of Allyldiphenylphosphine oxide derivatives have also been a focal point of recent research. Advanced spectroscopic techniques, including NMR and X-ray crystallography, have been employed to elucidate the structural nuances of these derivatives. These studies have provided insights into the compound's stability and reactivity under various conditions, which are essential for optimizing its applications in industrial and pharmaceutical settings.

In conclusion, the latest research on Allyldiphenylphosphine oxide (CAS 4141-48-4) underscores its multifaceted utility in chemical biology and medicine. From its role in asymmetric catalysis to its potential as a therapeutic agent, the compound continues to inspire innovative research. Future studies are expected to explore its applications in targeted drug delivery and combinatorial chemistry, further expanding its impact on the field.

• 91575-92-7((E,E)-2,4-Heptadienyldiphenylphosphine Oxide)
• 13067-78-2(Phosphine oxide, bis(2-methyl-2-propenyl)phenyl-)
• 58322-09-1(Phosphine oxide, [(2E)-3-methyl-2-penten-1-yl]diphenyl-)
• 5186-73-2(1H-Phosphole,2,5-dihydro-1-phenyl-, 1-oxide)
• 62412-26-4(Phosphine oxide, (3-methyl-2-pentenyl)diphenyl-, (Z)-)
• 4141-50-8(Phosphine oxide, 1,1'-(1,2-ethanediyl)bis[diphenyl-)
• 1733-57-9(Ethyl(phenyl)phosphorylbenzene)
• 52773-68-9( )
• 104723-30-0(3-Penten-2-one, 5-(diphenylphosphinyl)-, (E)-)
• 984-43-0(Phosphine oxide,[2-(diphenylphosphino)ethyl]diphenyl-)